Blocking the CXCL1-CXCR2 axis enhances the effects of doxorubicin in HCC by remodeling the tumor microenvironment via the NF-κB/IL-1𝛽/CXCL1 signaling pathwayHuiyong Zhao, Xiao Cui|Research Square|2023Cited by 0